Bavarian Nordic AS (CHIX:BAVAC) EPS without NRI: kr15.15 (TTM As of Mar. 2026)


CHIX:BAVAC Bavarian Nordic AS CHIX:BAVAC
84 GF Score
Price kr188.30
GF Value kr161.93
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bavarian Nordic AS EPS without NRI?

Bavarian Nordic AS CHIX:BAVAC 84 EPS without NRI is kr15.15 as of Mar. 2026. GuruFocus rates CHIX:BAVAC with a GF Score™ of 84/100 and a GF Value™ of kr161.93 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 1,167 Biotechnology companies, Bavarian Nordic AS ranks worse than 85689.72% on this metric.

Bavarian Nordic AS's earnings per share without non-recurring items for the three months ended in Mar. 2026 was kr0.20. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was kr15.15.

During the past 12 months, Bavarian Nordic AS's average earnings per share (NRI) Growth Rate was -8.90% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Bavarian Nordic AS's EPS without NRI or its related term are showing as below:

During the past 13 years, Bavarian Nordic AS's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 73.20% per year. The lowest was -66.80% per year. And the median was 9.80% per year.

CHIX:BAVAc's 3-Year EPS without NRI Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 16.6
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Bavarian Nordic AS's EPS (Diluted) for the three months ended in Mar. 2026 was kr0.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr15.10.

Bavarian Nordic AS's EPS (Basic) for the three months ended in Mar. 2026 was kr0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was kr15.10.


Bavarian Nordic AS  (CHIX:BAVAc) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Bavarian Nordic AS EPS without NRI Related Terms


Bavarian Nordic AS EPS without NRI Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS EPS without NRI Chart

Bavarian Nordic AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.92 -2.60 18.66 12.52 17.67

Bavarian Nordic AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.74 4.49 13.72 -3.26 0.20

CHIX:BAVAC vs VRTX, REGN, ALNY: EPS without NRI Comparison

For the Biotechnology subindustry, Bavarian Nordic AS's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic AS PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's PE Ratio without NRI falls into.


CHIX:BAVAC
84GF Score
Bavarian Nordic AS CHIX:BAVAC
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bavarian Nordic AS EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr15.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of kr15.15 mean?
Bavarian Nordic AS (CHIX:BAVAC) has a EPS without NRI of kr15.15 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Bavarian Nordic AS and its competitors. According to the industry distribution chart, Bavarian Nordic AS ranks #999999 out of 1167 companies in the Biotechnology industry.
Is Bavarian Nordic AS's EPS without NRI too high?
Bavarian Nordic AS's current EPS without NRI is kr15.15. Based on the distribution chart, Bavarian Nordic AS ranks #999999 out of 1167 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bavarian Nordic AS has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's EPS without NRI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bavarian Nordic AS ranks #999999 out of 1167 companies for EPS without NRI. This places Bavarian Nordic AS in the lower half of its industry. The industry median EPS without NRI is 16.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.60, based on 1,167 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Bavarian Nordic AS and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bavarian Nordic AS's current EPS without NRI is kr15.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr161.93, compared to a current price of kr188.30 — trading 16.3% above its estimated fair value. The current EPS without NRI is kr15.15. Bavarian Nordic AS's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current EPS without NRI is kr15.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr188.30 is trading 16.3% above its estimated GF Value™ of kr161.93. GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.

Key valuation signals for CHIX:BAVAC:

  • EPS without NRI: kr15.15
  • GF Value™: kr161.93 vs. price of kr188.30 (16.3% above fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
84GF Score

Get the complete analysis for CHIX:BAVAC

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr188.30
Price
kr161.93
GF Value